GCSH pseudogene 5 (GCSHP5)

GCSH pseudogene 5 is one of several pseudogenes related to the glycine cleavage system H protein (GCSH), a mitochondrial protein involved in glycine degradation in mammals[1][3]. Unlike the functional GCSH gene, pseudogenes such as GCSH pseudogene 5 do not encode an active protein due to frame disruptions or other mutations and are generally considered noncoding[2]. While some pseudogenes in the genome may serve as regulatory elements at the RNA level—such as through generation of noncoding RNAs or by acting as decoys for microRNAs—there are no references indicating this specific pseudogene has any such function[4][5]. It is not considered a therapeutic target, does not encode a receptor, enzyme, or relevant protein, and is not listed in drug or biomarker databases. The name "GCSHP5" is non-standard, and GCSH pseudogenes are typically only recognized in genomic annotation studies. GCSH pseudogene 5 (GCSHP5) is a noncoding pseudogene derived from the GCSH gene, with no known therapeutic, diagnostic, or pharmacological relevance. It is not a target, druggable entity, or biomarker and has no established biological or disease role. No drugs or mechanisms of action pertain to this pseudogene. The entry "GCSHP5" is non-standard and not used in scientific literature or drug development contexts[1][3].

Other names

Glycine cleavage system protein H pseudogene 5GCSH pseudogeneGCSHP5 (non-standard, inferred from the provided abbreviation)